FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. More Information Copyright © 2025 HealthDay. All rights reserved.
52 
Let's personalize your content